… a chitosan nanocarrier (NC)-based delivery of silver nanoparticles (Ag NPs) to mammalian
cells … of the Ag NP-nanocarrier (Ag-CS NC) system in human colon cancer cells (HT 29) was …

… The particle size considerably affects the uptake of nanocarriers by tumor cells and also RES
uptake. Alongside the lower sized particles also undergoes rapid clearance while particles …

… nanocarriers that have been used in tumor treatment. For the case (a), there are several
biodegradable nanoparticles such as PLGA, PLA, chitosan… Chitosan-based nanogels applied in …

… uptake of particles between normal and cancer cells, more apoptosis in cancer cells indicates
the release of curcumin within the cancer cells and showing the specific anticancer activity …

… major challenge for cancer treatment is to develop new types of smart nanocarriers that can
… blood circulation and quickly release the drug in tumor cells under stimulation. In this study, …

… are the non-specificity of nanocarriers in finding target cells in the whole body, partial
systemic side effects, cell membrane, and cytosol of cancer cells which have many drug-capturing …

… a chitosan based glycolipid-like nanocarrier (CSO-ss-SA) to selectively respond to the reducing
environment in tumor cells. … with the blood plasma, normal cells and tumor cells. And we …

… uptake and enhanced accumulation of the nanocarriers in tumor cells. The in vitro drug
release investigation resulted in a fast drug release, change of drug release mechanism from …

… In this study, chitosan-based nanocarriers were successfully fabricated and bound with
cisplatin by co-ordinate bonds between the carboxylic group of the polymer and the Pt centre of …

… Anticancer drugs via nanocarriers can be targeted on cancer cells using passive and
active targeting methods. In passive targeting inherent sizes of nanoparticles with unique …